IP Library Granted Patent US 10,299,986
Granted Patent B2
US 10,299,986 · App. 15/421,267 · Granted May 28, 2019

Methods and systems for treating cardiovascular disease using an implantable electroacupuncture device

Inventors: Jeffrey H. Greiner (Valencia, CA); David K. L. Peterson (Valencia, CA); Chuladatta Thenuwara (Castaic, CA)
Assignee: Valencia Technologies Corporation
A61H39/002A61H39/00A61N1/3606A61N1/36114A61N1/36117A61N1/36125A61N1/36175A61N1/3756A61N1/37205A61N1/37223A61H2201/01A61N1/36153A61N1/36157A61N1/3782A61N1/3787Y10T29/49002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,299,986
App. No.
15/421,267
Granted
May 28, 2019
Kind
B2
Abstract

An exemplary method treating a cardiovascular disease in a patient includes 1) generating, by an electroacupuncture device implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05, and 2) applying, by the electroacupuncture device in accordance with the duty cycle, the stimulation sessions to a median nerve of the patient by way of an electrode array located within the patient at an acupoint corresponding to the median nerve.

Claims (51)

1. A method of treating cardiovascular disease in a patient, comprising:

generating, by an electroacupuncture device implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05, wherein

each stimulation session included in the plurality of stimulation sessions comprises a series of stimulation pulses,

the duty cycle is a ratio of T 3 to T 4 ,

each stimulation session included in the stimulation sessions has a duration of T 3 minutes and occurs at a rate of once every T 4 minutes, and

the electroacupuncture device is powered by a primary battery located within the electroacupuncture device and having an internal impedance greater than 5 ohms; and

applying, by the electroacupuncture device in accordance with the duty cycle, the stimulation sessions to a median nerve of the patient by way of an electrode array located within the patient at an acupoint corresponding to the median nerve.

2. The method of claim 1 , wherein the primary battery located within the electroacupuncture device has a capacity of less than 60 milliamp-hours (mAh).

3. The method of claim 1 , wherein: a housing of the electroacupuncture device is coin-sized and coin-shaped; and the primary battery located within the electroacupuncture device is a coin-cell battery.

4. The method of claim 1 , wherein the primary battery located within the electroacupuncture device is not rechargeable.

5. The method of claim 1 , wherein the acupoint comprises PC6.

6. The method of claim 1 , wherein T 3 is at least 10 minutes and less than 60 minutes, and wherein T 4 is at least 1440 minutes.

7. The method of claim 1 , further comprising:

receiving, by the electroacupuncture device from a device external to the electroacupuncture device, a control command that sets the times T 3 and T 4 to appropriate values configured to treat the cardiovascular disease;

wherein the generating of the stimulation sessions is performed in accordance with the control command.

8. The method of claim 7 , wherein the receiving of the control command comprises detecting, with an electromagnetic field sensor included in the electroacupuncture device, a magnetic field generated by the device external to the electroacupuncture device.

9. The method of claim 1 , wherein:

the electrode array comprises a central electrode of a first polarity centrally located on a first surface of a housing of the electroacupuncture device and an annular electrode of a second polarity and that is spaced apart from the central electrode; and

the applying of the stimulation sessions to the median nerve by way of the electrode array comprises applying the stimulation sessions to the median nerve by way of the central electrode and the annular electrode.

10. The method of claim 9 , wherein the annular electrode is located on the first surface of the housing.

11. The method of claim 9 , wherein the annular electrode comprises a ring electrode located around a perimeter edge of the housing.

12. The method of claim 1 , wherein:

the electrode array comprises a plurality of electrodes located on a lead that is attached to the electroacupuncture device; and

the applying of the stimulation sessions to the median nerve by way of the electrode array comprises applying the stimulation sessions to the median nerve by way of the plurality of electrodes located on the lead.

13. A method of treating cardiovascular disease in a patient, comprising:

generating, by an electroacupuncture device implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05, wherein

each stimulation session included in the plurality of stimulation sessions comprises a series of stimulation pulses,

the duty cycle is a ratio of T 3 to T 4 ,

each stimulation session included in the stimulation sessions has a duration of T 3 minutes and occurs at a rate of once every T 4 minutes, and

the electroacupuncture device is powered by a primary battery located within the electroacupuncture device and having a capacity of less than 60 milliamp-hours (mAh); and

applying, by the electroacupuncture device in accordance with the duty cycle, the stimulation sessions to a median nerve of the patient by way of an electrode array located within the patient at an acupoint corresponding to the median nerve.

14. The method of claim 13 , wherein the primary battery located within the electroacupuncture device has an internal impedance greater than 5 ohms.

15. The method of claim 13 , wherein:

a housing of the electroacupuncture device is coin-sized and coin-shaped; and

the primary battery located within the electroacupuncture device is a coin-cell battery.

16. The method of claim 13 , wherein the primary battery located within the electroacupuncture device is not rechargeable.

17. An electroacupuncture device for treating cardiovascular disease in a patient, comprising:

a housing configured to be implanted beneath a skin surface of the patient,

pulse generation circuitry located within the housing, wherein the pulse generation circuitry is configured to

generate stimulation sessions at a duty cycle that is less than 0.05, and

apply, in accordance with the duty cycle, the stimulation sessions to a median nerve by way of an electrode array communicatively coupled to the pulse generation circuitry and configured to be located within the patient at an acupoint corresponding to a median nerve; and

a primary battery located within the housing and having an internal impedance greater than 5 ohms, the primary battery configured to provide operating power to the pulse generation circuitry;

wherein

each stimulation session included in the stimulation sessions comprises a series of stimulation pulses,

the duty cycle is a ratio of T 3 to T 4 , and

each stimulation session included in the stimulation sessions has a duration of T 3 minutes and occurs at a rate of once every T 4 minutes.

18. The electroacupuncture device of claim 17 , wherein the primary battery located within the housing has a capacity of less than 60 milliamp-hours (mAh).

19. The electroacupuncture device of claim 17 , wherein:

a housing of the electroacupuncture device is coin-sized and coin-shaped; and

the primary battery located within the housing is a coin-cell battery.

20. The electroacupuncture device of claim 17 , wherein the primary battery located within the housing is not rechargeable.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 6, 2026
From: MEDTRONIC, INC.
To: VALENCIA BIOSCIENCE, INC.
Reel/Frame 075721/0223 →
SECURITY INTEREST Recorded Oct 27, 2023
From: VALENCIA BIOSCIENCE, INC.
To: MEDTRONIC, INC.
Reel/Frame 065382/0738 →
SECURITY INTEREST Recorded Aug 4, 2021
From: VALENCIA BIOSCIENCE, INC.
To: MEDTRONIC, INC.
Reel/Frame 057088/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2020
From: VALENCIA TECHNOLOGIES CORPORATION
To: VALENCIA BIOSCIENCE, INC.
Reel/Frame 053684/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2017
From: GREINER, JEFFREY H.; PETERSON, DAVID K. L.; THENUWARA, CHULADATTA
To: VALENCIA TECHNOLOGIES CORPORATION
Reel/Frame 041138/0841 →
Continuity (12)
Continuation 14805346 · Jul 21, 2015
Continuation 14669155 · Mar 26, 2015
Division 13622653 · Sep 19, 2012
Provisional Application 61626339 · Sep 23, 2011
Provisional Application 61606995 · Mar 6, 2012
Provisional Application 61609875 · Mar 12, 2012
Provisional Application 61672257 · Jul 16, 2012
Provisional Application 61672661 · Jul 17, 2012
Provisional Application 61673254 · Jul 19, 2012
Provisional Application 61674691 · Jul 23, 2012
Provisional Application 61676275 · Jul 26, 2012
Related Publication 20170202738A1 · Jul 20, 2017
Cited By (2)
US 12,527,955 US 12,605,542